3 completed, 1 active not recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow jCyte, Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) human retinal progenitor cells, Mock injection - Retinitis Pigmentosa | Phase 2 | Active not recruiting | jCyte, Inc | 31 | 2025-06-20 | 2026-07-30 |
| Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa human retinal progenitor cells - Retinitis Pigmentosa | Phase 2 | Completed | jCyte, Inc | 30 | 2020-12-01 | 2024-07-16 |
| Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa human retinal progenitor cells, Mock injection - Retinitis Pigmentosa | Phase 2 | Completed | jCyte, Inc | 84 | 2017-03-01 | 2024-06-18 |
| Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa human retinal progenitor cells - Retinitis Pigmentosa (RP) | Phase 1 / Phase 2 | Completed | jCyte, Inc | 28 | 2015-06-01 | 2019-03-05 |
United States (4)
David Liao, MD (2) · Mitul Mehta, MD (2) · Anthony Joseph, MD (1) · Anthony Jospeh, MD (1) · Baruch Kuppermann, MD (1) · Henry Klassen, MD, PhD (1)